Epigenetic regulation of mitochondrial-endoplasmic reticulum dynamics in kidney diseases

Vishwadeep Shelke1, Vinayak Yelgonde1, Ajinath Kale1

  • 1Laboratory of Molecular Pharmacology, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Pilani, Rajasthan, India.

PubMed

Insights

Epigenetic regulation of organelle dynamics, including mitochondria and endoplasmic reticulum (ER) interactions, is crucial for kidney health. Understanding these mechanisms offers novel therapeutic targets for kidney diseases.

Area of Science:

  • Cellular Biology
  • Nephrology
  • Epigenetics

Background:

  • Kidney diseases affect over 800 million people globally, necessitating advanced treatments.
  • Pathophysiology involves complex organelle dysfunctions, particularly mitochondria and endoplasmic reticulum (ER).
  • Mitochondria-ER contacts are vital for cellular homeostasis and kidney physiology.

Purpose of the Study:

  • To review the role of epigenetic mechanisms in regulating organelle dynamics in kidney diseases.
  • To elucidate stress origins in organelles contributing to kidney disease.
  • To highlight epigenetic regulation as a potential therapeutic strategy for kidney diseases.

Main Methods:

  • Review of current literature on organelle dynamics and epigenetic regulation in kidney disease.
  • Analysis of molecular events linking ER-mitochondria interactions to kidney pathophysiology.
  • Exploration of epigenetic modifications (DNA methylation, histone modifications, noncoding RNAs) in kidney disease models.

Main Results:

  • Mitochondria-ER contacts regulate key signaling pathways like apoptosis, calcium transport, and autophagy.
  • Epigenetic mechanisms intricately control organelle dynamics and cellular functions.
  • Dysregulation of these epigenetic pathways contributes to kidney disease development.

Conclusions:

  • Epigenetic regulation of organelle dynamics is a critical factor in kidney health and disease.
  • Targeting epigenetic mechanisms offers a promising novel therapeutic avenue for kidney diseases.
  • Further research into epigenetic control of mitochondria-ER interactions is warranted for effective intervention.

Related Concept Videos

Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.6K
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
5.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.6K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
43
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
48